Curevac N V (CVAC)

Dec 08, 2025

Trading Recap: Chien thuat ca cuoc dai han de kiem tienQuarterly Earnings Summary & Daily Growth Stock Tips - BỘ NỘI VỤ

Dec 08, 2025

Dec 05, 2025

Can CureVac N.V. stock reach $100 price targetWeekly Trade Analysis & Free Risk Controlled Daily Trade Plans - Newser

Dec 05, 2025

Dec 04, 2025

CureVac N.V. (CVAC): A Bull Case Theory - Finviz

Dec 04, 2025

Dec 04, 2025

Can CureVac N.V. stock sustain market leadershipGlobal Markets & Proven Capital Preservation Tips - Newser

Dec 04, 2025

Dec 03, 2025

BioNTech Satisfies Minimum Condition in CureVac Exchange Offer - TipRanks

Dec 03, 2025

Dec 03, 2025

BioNTech satisfies minimum condition in CureVac exchange offer - MSN

Dec 03, 2025

Dec 03, 2025

Biontech achieves minimum condition in CureVac exchange offer - marketscreener.com

Dec 03, 2025

Dec 03, 2025

BioNTech Achieves Minimum Condition in CureVac Exchange Offer - The Manila Times

Dec 03, 2025

Dec 03, 2025

BioNTech Announces Successful Tender of Over 81% of CureVac Shares, Subsequent Offering Period Now Open - Quiver Quantitative

Dec 03, 2025

Dec 03, 2025

BioNTech Achieves Minimum Condition in CureVac Exchange Offer - Benzinga

Dec 03, 2025

Dec 02, 2025

Movement Recap: Can MFSG stock resist broad market declinesQuarterly Performance Summary & Free Low Drawdown Momentum Trade Ideas - BỘ NỘI VỤ

Dec 02, 2025

Nov 30, 2025

Can New Board Leadership at CureVac (CVAC) Shift the Narrative After Recent Earnings Decline? - simplywall.st

Nov 30, 2025

Nov 30, 2025

CureVac NV Faces Valuation Shift Amid Declining Financial Performance Indicators - Markets Mojo

Nov 30, 2025

Nov 29, 2025

How CureVac N.V. stock reacts to Fed rate cutsEarnings Risk Report & Reliable Volume Spike Trade Alerts - BỘ NỘI VỤ

Nov 29, 2025

Nov 28, 2025

Carlson Capital L.P. Makes New Investment in CureVac N.V. $CVAC - MarketBeat

Nov 28, 2025

Nov 28, 2025

Transcript : CureVac N.V.Shareholder/Analyst Call - MarketScreener

Nov 28, 2025

Nov 27, 2025

CureVac (NASDAQ:CVAC) Sees Large Volume IncreaseHere's What Happened - MarketBeat

Nov 27, 2025

Nov 26, 2025

BioNTech Advances with CureVac Exchange Offer Approval - TipRanks

Nov 26, 2025

Nov 26, 2025

[6-K] BioNTech SE Current Report (Foreign Issuer) | BNTX SEC FilingForm 6-K - Stock Titan

Nov 26, 2025

Nov 26, 2025

CureVac Reports Q3 2025 Financial Results and Updates - MSN

Nov 26, 2025

Nov 26, 2025

CureVac Shareholders Approve BioNTech Exchange Offer - TipRanks

Nov 26, 2025

Nov 26, 2025

BioNTech’s acquisition of CureVac nears completion as offer deadline approaches - Investing.com Nigeria

Nov 26, 2025

Nov 26, 2025

CureVac Form 6-K files EGM voting outcomes, joins BioNTech F-4 - Stock Titan

Nov 26, 2025

Nov 26, 2025

BioNTech (BNTX) Moves Forward with CureVac Acquisition - GuruFocus

Nov 26, 2025

Nov 26, 2025

BioNTech’s exchange offer for German mRNA vaccine peer CureVac set to expire Dec. 3 - Seeking Alpha

Nov 26, 2025

Nov 26, 2025

BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration - The Manila Times

Nov 26, 2025

Nov 26, 2025

BioNTech Completes CureVac Share Exchange Offer Following Shareholder Approval - Quiver Quantitative

Nov 26, 2025

Nov 26, 2025

BioNTech Says CureVac Shareholders Are Advised To Tender Their Shares By 6:00 P.M. Eastern Time On Tuesday, December 2, 2025 - TradingView

Nov 26, 2025

Nov 26, 2025

BioNTech exchange offer for CureVac expires December 3 - StreetInsider

Nov 26, 2025

Nov 26, 2025

CureVac NV earnings beat by €0.08, revenue topped estimates - Investing.com South Africa

Nov 26, 2025

Nov 26, 2025

CureVac NV (FRA:5CV) PS Ratio : 14.01 (As of Nov. 25, 2025) - GuruFocus

Nov 26, 2025

Nov 25, 2025

EQS-News: CureVac Announces Voting Results of Extraordinary General Meeting - sharewise.com

Nov 25, 2025

Nov 25, 2025

CureVac (Nasdaq: CVAC) shareholders approve BioNTech exchange offer with 99.16% vote - Stock Titan

Nov 25, 2025

Nov 25, 2025

CureVac Announces Voting Results of Extraordinary General Meeting - The Derrick

Nov 25, 2025

Nov 25, 2025

How Investors May Respond To CureVac (CVAC) Reporting Sharp Decline in Quarterly Sales - Yahoo Finance

Nov 25, 2025

Nov 25, 2025

CureVac Beats Revenue Forecasts As BioNTech Takeover Advances - Finimize

Nov 25, 2025

Nov 25, 2025

CureVac (NASDAQ:CVAC) Releases Quarterly Earnings Results, Beats Expectations By $0.07 EPS - MarketBeat

Nov 25, 2025

Nov 25, 2025

CureVac: Acquisition proceeding as planned; cash runway confirmed through 2028 - marketscreener.com

Nov 25, 2025

Nov 25, 2025

Company News for Nov 25, 2025 - sharewise.com

Nov 25, 2025

Nov 24, 2025

CureVac N.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener

Nov 24, 2025

Nov 24, 2025

MSN Money - MSN

Nov 24, 2025

Nov 24, 2025

CureVac Reports Q3 2025 Financials and BioNTech Transaction Progress - TipRanks

Nov 24, 2025

Nov 24, 2025

CVAC: Q3 2025 profit driven by one-time U.S. settlement, despite sharp revenue drop - TradingView

Nov 24, 2025

Nov 24, 2025

EQS-News: CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2025 and Provides Business Updates - sharewise.com

Nov 24, 2025

Nov 24, 2025

Nasdaq Surges 350 Points; Enlivex Therapeutics Shares Spike Higher - Benzinga

Nov 24, 2025

Nov 24, 2025

[6-K] CureVac N.V. Current Report (Foreign Issuer) | CVAC SEC FilingForm 6-K - Stock Titan

Nov 24, 2025

Nov 24, 2025

CureVac BV (CVAC) Reports Q3 Earnings with Strong Cash Position - GuruFocus

Nov 24, 2025

Nov 24, 2025

CureVac (CVAC) Reports Decrease in Q3 EPS - GuruFocus

Nov 24, 2025

Nov 24, 2025

CureVac (CVAC) Moves Closer to BioNTech Deal for mRNA Innovations - GuruFocus

Nov 24, 2025